Deutsch English Français

Contact

EP1696931

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1696931

EP1696931 - AMINO SUBSTITUTED DIARYL[A,D]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS [Right-click to bookmark this link]
Former [2006/36]	AMINO SUBSTITUTED DIARYL [A,D]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS
	[2008/28]
Status	No opposition filed within time limit Status updated on 29.01.2010 Database last updated on 28.06.2024
Most recent event Tooltip	29.01.2010	No opposition filed within time limit	published on 03.03.2010 [2010/09]
Applicant(s)	For all designated states Acadia Pharmaceuticals Inc. 3911 Sorrento Valley Blvd. San Diego, CA 92121-1402 / US
	[2006/36]
Inventor(s)	01 / EK, Fredrik Hillebardsgränd 2 S-226 49 Lund / SE
	02 / OLSSON, Roger Klagshamnskagen 99A S-23044 Bunkeflo Strand / SE
	03 / OHLSSON, Jörgen Femmötesvägen 16 S-247 33 S Sandby / SE
	[2006/52]
Former [2006/36]	01 / EK, Fredrik Dag Hammarskjoldsv, 55 S-224 64 Lund / SE
	02 / OLSSON, Roger Klagshamnskagen 99A S-23044 Bunkeflo Strand / SE
	03 / OHLSSON, Jörgen Jägaregatan 44 S-226 53 Lund / SE
Representative(s)	Plougmann Vingtoft a/s Strandvejen 70 2900 Hellerup / DK
	[N/P]
Former [2008/31]	Plougmann & Vingtoft A/S Sundkrogsgade 9 P.O. Box 831 2100 Copenhagen Ø / DK
Former [2006/36]	Plougmann & Vingtoft A/S Sundkrogsgade 9 P.O. Box 831 DK-2100 Copenhagen OE / DK
Application number, filing date	04815318.3	21.12.2004
	[2006/36]
	WO2004US43224
Priority number, date	US20030531927P	22.12.2003 Original published format: US 531927 P
	US20040548090P	24.02.2004 Original published format: US 548090 P
	US20040548604P	27.02.2004 Original published format: US 548604 P
	[2006/36]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2005063254
	Date:	14.07.2005
	Language:	EN
	[2005/28]
	Type:	A2 Application without search report
	No.:	EP1696931
	Date:	06.09.2006
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 14.07.2005 takes the place of the publication of the European patent application.
	[2006/36]
	Type:	B1 Patent specification
	No.:	EP1696931
	Date:	25.03.2009
	Language:	EN
	[2009/13]
Search report(s)	International search report - published on:	EP	15.09.2005
Classification	IPC:	A61K31/551, A61P25/28, C07D403/04, C07D405/04	[2008/28]
	CPC:	C07D413/04 (EP,US); C07D401/04 (KR); A61P25/00 (EP); A61P25/14 (EP); A61P25/18 (EP); A61P25/20 (EP); (+) A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP); C07D243/38 (KR); C07D417/04 (KR) (-)
	Former IPC [2006/36]	A61K31/551, A61P25/28, C07D403/04
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/36]
Extension states	AL	Not yet paid
	BA	Not yet paid
	HR	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	YU	Not yet paid
Title	German:	AMINO-SUBSTITUIERTE DIARYL[A,D]CYCLOHEPTEN- ANALOGA ALS MUSCARINISCHE AGONISTEN UND VERFAHREN ZUR BEHANDLUNG VON NEUROPSYCHIATRISCHEN ERKRANKUNGEN	[2008/28]
	English:	AMINO SUBSTITUTED DIARYL[A,D]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS	[2008/28]
	French:	ANALOGUES DE DIARYL[A,D]CYCLOHEPTENE AMINO SUBSTITUES UTILISES COMME AGONISTES MUSCARINIQUES, ET PROCEDES DE TRAITEMENT DE TROUBLES NEUROPSYCHIATRIQUES	[2008/28]
	Former [2006/36]	AMINO-SUBSTITUIERTE DIARYL [A,D]CYCLOHEPTEN- ANALOGA ALS MUSCARINISCHE AGONISTEN UND VERFAHREN ZUR BEHANDLUNG VON NEUROPSYCHIATRISCHEN ERKRANKUNGEN
	Former [2006/36]	AMINO SUBSTITUTED DIARYL [A,D]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS
	Former [2006/36]	ANALOGUES DE DIARYL [A,D]CYCLOHEPTENE AMINO SUBSTITUES UTILISES COMME AGONISTES MUSCARINIQUES, ET PROCEDES DE TRAITEMENT DE TROUBLES NEUROPSYCHIATRIQUES
Entry into regional phase	29.06.2006	National basic fee paid
	29.06.2006	Designation fee(s) paid
	29.06.2006	Examination fee paid
Examination procedure	11.11.2005	Request for preliminary examination filed International Preliminary Examining Authority: EP
	29.06.2006	Examination requested [2006/36]
	11.09.2006	Amendment by applicant (claims and/or description)
	25.09.2006	Despatch of a communication from the examining division (Time limit: M06)
	02.04.2007	Reply to a communication from the examining division
	28.06.2007	Despatch of a communication from the examining division (Time limit: M04)
	06.11.2007	Reply to a communication from the examining division
	07.07.2008	Communication of intention to grant the patent
	07.11.2008	Fee for grant paid
	07.11.2008	Fee for publishing/printing paid
Divisional application(s)	EP09155868.4 / EP2088147
Opposition(s)	29.12.2009	No opposition filed within time limit [2010/09]
Fees paid	Renewal fee
	29.06.2006	Renewal fee patent year 03
	12.12.2007	Renewal fee patent year 04
	15.12.2008	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]FR870763 (ZEISS IKON AG) [X] 1-59,62-83 * examples 1-60 *;
		[X]CH240228 (CIBA GEIGY [CH]) [X] 1-59,62-83 * the whole document *;
		[X]FR939595 (DR. A. WANDER AG) [X] 1-59,62-83 * examples 1-24 *;
		[X]FR1334944 (WANDER AG DR A) [X] 1-59,62-83 * table II *;
		[X]CH422793 (WANDER AG DR A [CH]) [X] 1-59,62-83 * table II *;
		[X]CH476753 (WANDER AG DR A [CH]) [X] 1-59,62-83 * table II *;
		[X]CH493538 (AMERICAN CYANAMID CO [US]) [X] 1-59,62-83 * examples 1-26; compound (I) *;
		[X]CH499539 (WANDER AG DR A [CH]) [X] 1-59,62-83 * the whole document *;
		[X]GB1216523 (WANDER S A A [CH]) [X] 1-59,62-83 * table *;
		[X]FR2222102 (WANDER AG DR A [CH]) [X] 1-59,62-83 * examples 1-5; claims 1-20; table I *;
		[X]DE2625258 (HOFFMANN LA ROCHE) [X] 1-59,62-83 * examples, claims *;
		[X]US4045445 (HARDY JR ROBERT ALLIS, et al) [X] 1-59,62-83 * examples 1-17; claims 1-20 *;
		[X]US4096261 (HORROM BRUCE WAYNE, et al) [X] 1-59,62-83 * examples, claims *;
		[X]US4097597 (HORROM BRUCE WAYNE, et al) [X] 1-59,62-83 * examples, claims *;
		[X]CH601288 (SANDOZ AG) [X] 1-59,62-83 * the whole document *;
		[X]DD133235 (RUEGER CARLA, et al) [X] 1-59,62-83 * examples 1-6; compound (I) *;
		[X]GB1554275 (SANDOZ LTD) [X] 1-59,62-83 * examples 1-20 *;
		[X]US4263207 (ROKACH JOSHUA, et al) [X] 1-59,62-83 * claims 1-21 *;
		[X]US4404137 (CHAKRABARTI JIBAN K [GB], et al) [X] 1-59,62-83 * examples, claims *;
		[X]EP0240228 (ICI AMERICA INC [US]) [X] 1-59,62-83 * examples, claims *;
		[X]WO9307143 (THERABEL RESEARCH SA [BE]) [X] 1-59,62-83 * examples 1-21; claims 1-9 *;
		[X]US5393752 (LIEGEOIS JEAN-FRANCOIS F [BE], et al) [X] 1-59,62-83 * examples, claims *;
		[X]WO9629316 (WIKSTROEM HAAKAN [NL], et al) [X] 1-59,62-83 * examples, claims;; claims 1-10; table 1; compounds 7,8,12,15-20 *;
		[X]US5700445 (FU JIAN-MIN [CA], et al) [X] 1-59,62-83 * examples, claims *;
		[X]US5817655 (CHAKRABARTI JIBAN KUMAR [GB], et al) [X] 1-59,62-83 * examples, claims *;
		[X]WO03082877 (LILLY CO ELI [US], et al) [X] 1-59,62-83* examples 568-584; claims 1-56 *;
		[I] - SUR C ET AL, "N-DESMETHYLCLOZAPINE, AN ALLOSTERIC AGONIST AT MUSCARINIC 1 RECEPTOR, POTENTIATES N-METHYL-D-ASPARTATE RECEPTOR ACTIVITY", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, (20031111), vol. 100, no. 23, ISSN 0027-8424, pages 13674 - 13679, XP001191264 [I] 1-59,61-83 * table 2 * DOI: http://dx.doi.org/10.1073/pnas.1835612100

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p